Amazon Pharmacy offers weight-loss drugs for $50 a month through Medicare bridge program

Amazon Pharmacy said it will offer eligible Medicare beneficiaries weight-loss drugs for $50 a month through the new federal Medicare Bridge program, expanding access to popular GLP-1 treatments such as Wegovy and Zepbound-related products. The service automates eligibility checks, prior authorization, and billing, while adding home delivery and in-store pickup to speed access and reduce administrative friction. Reuters notes that most Bridge patients at Amazon received prior authorization decisions in under 24 hours, better than the program’s 72-hour allowance, and many submitted claims have already turned into completed orders. The move underscores Amazon’s push to deepen its healthcare footprint via One Medical and pharmacy services, and could increase competitive pressure in drug distribution and patient access channels. The article is likely positive for Amazon’s healthcare strategy but has limited direct revenue impact near term.